Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Parmar

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto beta-boswellic acid in human plasma by high-performance thin-layer chromatographyShailesh A Shah, Ishwarsinh S Rathod, Bhanubhai N Suhagia, et al.
Annals of the Royal College of Surgeons of England|May 26, 2022
Predictors of mortality and nephrectomy in emphysematous pyelonephritis: a tertiary care centre studyD Aggarwal, S Mandal, K Parmar, et al.
British Journal of Urology|August 1, 1992
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)S D Fosså, S J Harland, S B Kaye, et al.
Molecular Pharmaceutics|March 15, 2022
Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human VolunteersNimmy Kumari, Parag Roy, Sukanta Roy, et al.
British Journal of Urology|August 1, 1991
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladderJ T Roberts, S D Fossa, B Richards, et al.
Molecular Cancer Therapeutics|September 21, 2014
Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumorsTao Wang, Shenghong Yang, Leslie A Mei, et al.
BMJ Open|April 21, 2021
Integrating community health volunteers into non-communicable disease management among Syrian refugees in Jordan: a causal loop analysisParveen K Parmar, Fatma Rawashdah, Nahla Al-Ali, et al.
Conflict and Health|September 20, 2019
Qualitative evidence of crimes against humanity: the August 2017 attacks on the Rohingya in northern Rakhine State, MyanmarNicole Messner, Andrea Woods, Agnes Petty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Thirty years of Medical Research Council randomized trials in solid tumoursD Machin, S P Stenning, M K Parmar, et al.
Journal of the National Cancer Institute|September 21, 2000
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer IntergroupI Vergote, G J Rustin, E A Eisenhauer, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto beta-boswellic acid in human plasma by high-performance thin-layer chromatographyShailesh A Shah, Ishwarsinh S Rathod, Bhanubhai N Suhagia, et al.
Annals of the Royal College of Surgeons of England|May 26, 2022
Predictors of mortality and nephrectomy in emphysematous pyelonephritis: a tertiary care centre studyD Aggarwal, S Mandal, K Parmar, et al.
British Journal of Urology|August 1, 1992
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)S D Fosså, S J Harland, S B Kaye, et al.
Molecular Pharmaceutics|March 15, 2022
Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human VolunteersNimmy Kumari, Parag Roy, Sukanta Roy, et al.
British Journal of Urology|August 1, 1991
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladderJ T Roberts, S D Fossa, B Richards, et al.
Molecular Cancer Therapeutics|September 21, 2014
Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumorsTao Wang, Shenghong Yang, Leslie A Mei, et al.
BMJ Open|April 21, 2021
Integrating community health volunteers into non-communicable disease management among Syrian refugees in Jordan: a causal loop analysisParveen K Parmar, Fatma Rawashdah, Nahla Al-Ali, et al.
Conflict and Health|September 20, 2019
Qualitative evidence of crimes against humanity: the August 2017 attacks on the Rohingya in northern Rakhine State, MyanmarNicole Messner, Andrea Woods, Agnes Petty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Thirty years of Medical Research Council randomized trials in solid tumoursD Machin, S P Stenning, M K Parmar, et al.
Journal of the National Cancer Institute|September 21, 2000
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer IntergroupI Vergote, G J Rustin, E A Eisenhauer, et al.
Pageof 21